Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 11/20 | 0.72 |
| ▸ | CA12 | O43570 | 4/20 | 0.72 |
| ▸ | CA1 | P00915 | 4/20 | 0.72 |
| ▸ | CA7 | P43166 | 3/20 | 0.72 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | APAF1 | O14727 | 1/20 | 0.41 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | TDP2 | O95551 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL811988 | 0.94 | CA2 (0.66) | CA2CA12CA1CA7CA13 | |
| SCHEMBL3137951 | 0.89 | CA2 (0.59) | CA2CA12CA1CA7CA13 | |
| SCHEMBL14351561 | 0.88 | CA2 (0.74) | CA2CA12CA1CA7CA13 | |
| Acrylic Acid SCHEMBL6631376 | 0.87 | CA2 (0.57) | CA2CA12CA1CA7CA13 | |
| SCHEMBL10532586 | 0.84 | CA2 (1.00) | CA2CA12CA1CA7CA13 | |
| SCHEMBL811362 | 0.84 | CA2 (0.54) | CA2CA12CA1CA7CA13 | |
| SCHEMBL811796 | 0.84 | CA2 (0.54) | CA2CA12CA1CA7CA13 | |
| SCHEMBL8637757 | 0.82 | CA2 (0.61) | CA2CA12CA1CA7CA13 | |
| SCHEMBL13696518 | 0.80 | CA2 (0.49) | CA2CA12CA1CA7CA13 | |
| SCHEMBL3139223 | 0.79 | CA2 (0.47) | CA2CA12CA1CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4663693-A1 | METHOD FOR DECOMPOSING COMPOUND | National Institute Of Advanced Industrial Science and Technology (JP) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024166919-A1 | METHOD FOR DECOMPOSING COMPOUND | 国立研究開発法人産業技術総合研究所 | 2024-08-15 | — | — | WO | disclosed |
| US-9365507-B2 | Diaryl sulfone compound, and manufacturing method for same | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2016-06-14 | — | — | US | disclosed |
| EP-2548860-A1 | NOVEL DIARYL SULFONE COMPOUND, AND MANUFACTURING METHOD FOR SAME | Sumitomo Seika Chemicals CO. LTD. (JP) | 2013-01-23 | — | — | EP | disclosed |
| US-20130005982-A1 | NOVEL DIARYL SULFONE COMPOUND, AND MANUFACTURING METHOD FOR SAME | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2013-01-03 | — | — | US | disclosed |
| WO-2011083652-A1 | ACTINIC-RADIATION CURABLE COMPOSITION AND USES THEREOF | 日本合成化学工業株式会社 (JP) | 2011-07-14 | — | — | WO | disclosed |
| EP-2139878-A2 | HIGH REFRACTIVE INDEX MONOMERS, COMPOSITIONS AND USES THEREOF | BASF SE (DE) | 2010-01-06 | — | — | EP | disclosed |
| US-20090220770-A1 | POLYMERIZABLE COMPOSITION, HIGH-REFRACTIVE-INDEX RESIN COMPOSITION, AND OPTICAL MEMBER MADE OF THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-09-03 | — | — | US | disclosed |
| WO-2008101806-A2 | HIGH REFRACTIVE INDEX MONOMERS, COMPOSITIONS AND USES THEREOF | BASF SE (CH) | 2008-08-28 | — | — | WO | disclosed |
| US-20080200582-A1 | High refractive index monomers, compositions and uses thereof | CIBA CORP. | 2008-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130005982-A1 | NOVEL DIARYL SULFONE COMPOUND, AND MANUFACTURING METHOD FOR SAME | SULT1A1, SULT1E1, SULT2A1 | CA2 3589/4885CA12 2809/4885CA1 2431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.